The Journal of Urology
Volume 170, Issue 5 , Pages 1717-1721 , November 2003

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

,Accepted 9 May 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Editor’s Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1982 and 1983.Supported by National Institutes of Health General Clinical Research Centers Program (National Center for Research Resources Grant M01RR00047), U.S. Department of Army Grant DAMD17-98-1-8594, the Cancer Research Institute, CaPCURE, the David H. Koch Foundation, the Peter Sacerdote Foundation, the Yablans Research Fund and the Gerschel Research Fund.

PII: S0022-5347(05)62918-7

doi: 10.1097/01.ju.0000091655.77601.0c

The Journal of Urology
Volume 170, Issue 5 , Pages 1717-1721 , November 2003

Article Tools

* Image Usage & Resolution